1999
DOI: 10.1016/s0968-0896(99)00082-6
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and pharmacological evaluation of the R - and S -enantiomers of 3-(2′-butylamino)-4 H - and 3-(3′-methyl-2′-butylamino)-4 H -pyrido[4,3- e ]-1,2,4-thiadiazine 1,1-dioxide, two tissue selective ATP-sensitive potassium channel openers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
27
0

Year Published

2000
2000
2022
2022

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 21 publications
(31 citation statements)
references
References 11 publications
4
27
0
Order By: Relevance
“…For drugs exhibiting a stereogenic center on the 3-alkylamino side chain, only the racemates were introduced in the study and built as the R -enantiomeric structure. This necessary arbitrary choice was driven by classical SAR deduced from the comparison of biological data obtained with ( R )- and ( S )-BPDZ 42 and -BPDZ 44 enantiomers …”
Section: Computational Detailsmentioning
confidence: 99%
“…For drugs exhibiting a stereogenic center on the 3-alkylamino side chain, only the racemates were introduced in the study and built as the R -enantiomeric structure. This necessary arbitrary choice was driven by classical SAR deduced from the comparison of biological data obtained with ( R )- and ( S )-BPDZ 42 and -BPDZ 44 enantiomers …”
Section: Computational Detailsmentioning
confidence: 99%
“…13 Four polymorphs of (S)-naproxen have been claimed, but three of them have been obtained under extreme crystallization conditions. Four naproxen cocrystals [14][15][16][17] and eight salts [18][19][20][21][22][23][24][25] have been recorded in the Cambridge Structural Database (CSD), 26 underlining the interest for this compound in solid-state studies. To diversify the structural study, we considered all possible chiral combinations between both partners as shown in Table 1.…”
Section: Introductionmentioning
confidence: 99%
“…We previously synthesized 3-alkylamino-4Hpyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides, with different aminoalkyl side-chains in the 3-position (Pirotte et al 1993(Pirotte et al , 1994de Tullio et al 1996;Lebrun et al 1996), which can be regarded as hybrid compounds between diazoxide and pinacidil ( Figure 1). Pharmacological investigation has recently shown that compounds such as BPDZ 42 (3-(2 H -butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide) and BPDZ 44 (3-(3 H -methyl-2 Hbutylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1dioxide) have the pharmacological pro®les of K ATP -channel openers (Pirotte et al 1994;Khelili et al 1999). In contrast with diazoxide, which is devoid of tissue selectivity, these two pyridothiadiazine dioxides seemed to be more active on endocrine pancreatic tissue (inhibition of insulin release) than on vascular tissue.…”
mentioning
confidence: 99%